Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00327
|
|||||
| Drug Name |
Benzbromarone
|
|||||
| Synonyms |
(2-Ethyl-3-benzofuranyl)-(3,5-dibrom-4-hydroxyphenyl)keton; (3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone; (3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-1-benzofuran-3-yl)methanone; 2-Ethyl-3-(3,5-dibrom-4-hydroxybenzoyl)benzofuran; 3, 5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone; 3,5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone; 3-(3,5-Dibromo-4-hydroxybenzoyl)-2-ethylbenzofuran; 3-[3,5-DIBROMO-4-HYDROXYBENZOYL]-2-ETHYLBENZOFURAN; AL, Benzbromaron; Acifugan; Aliud Brand of Benzbromarone; Azubromaron; Benzbromaron; Benzbromaron AL; Benzbromaron ratiopharm; Benzbromaron-ratiopharm; Benzbromarone (JP15/USAN/INN); Benzbromarone Aliud Brand; Benzbromarone Heumann Brand; Benzbromarone Sanfer Brand; Benzbromarone [USAN:INN:BAN]; Benzbromarone ratiopharm Brand; Benzbromaronratiopharm; Benzbromaronum; Benzbromaronum [INN-Latin]; Benzobromarona; Benzobromarona [INN-Spanish]; Besuric; Desuric; Exurate; Harolan; Heumann Brand of Benzbromarone; Hipurik; KETONE, 3,5-DIBROMO-4-HYDROXYPHENYL 2-ETHYL-3-BENZOFURANYL; L 2214; L 2214-Labaz; L-2214; L2214; MJ 10061; Methanone, (3; Minuric; NCI85433; Narcaricin; Normurat; Ratiopharm Brand of Benzbromarone; Sanfer Brand of Benzbromarone; Sanofi Winthrop Brand of Benzbromarone; Uricovac; Urinorm; Uroleap; Uroleap (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Gout [ICD11: FA25] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H12Br2O3
|
|||||
| Canonical SMILES |
CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br
|
|||||
| InChI |
InChI=1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3
|
|||||
| InChIKey |
WHQCHUCQKNIQEC-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 3562-84-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 424.1 | Topological Polar Surface Area | 50.4 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
5.7
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10320943
, 10321664
, 103513016
, 103914152
, 11110651
, 11446236
, 11458917
, 11461081
, 11466398
, 11467518
, 11486156
, 11533498
, 122758
, 15329540
, 221763
, 24424558
, 24891861
, 26653345
, 26664708
, 29221503
, 4253342
, 4572619
, 46386951
, 47291274
, 47810917
, 47959937
, 48185143
, 48259414
, 48415612
, 49681786
, 49698460
, 49988150
, 50100155
, 50103990
, 50804618
, 56422114
, 57321259
, 57653945
, 76715662
, 7848119
, 8139271
, 8151561
, 855676
, 85787503
, 89471954
, 92125465
, 92308014
, 92308634
, 92722452
, 99450936
|
|||||
| ChEBI ID |
ChEBI:3023
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MRP6 | Transporter Info | Multidrug resistance-associated protein 6 | Substrate | [2] | |
| References | ||||||
| 1 | A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients? Drug Saf. 2008;31(8):643-65. | |||||
| 2 | The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016 Jan 4;44(D1):D372-9. (ID: 3.A.1.208.10) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.